GLP Watchdog

Aurelius Health Group vs Navio MD

Neither Aurelius Health Group nor Navio MD has an FDA warning letter on record. On compounded tirzepatide injection, Navio MD costs $120 less a year at standing rates: $189 a month against $199 a month at Aurelius Health Group.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Aurelius Health Group / Navio MD

Aurelius Health Group logo

Aurelius Health Group

7.4/10

Navio MD logo

Navio MD

8.5/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$199/moCompounded tirzepatide injection
$189/moCompounded tirzepatide injection
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit siteFull review
Visit Navio MDFull review

Neither Aurelius Health Group nor Navio MD pays us. Links to them earn nothing. Scores: Aurelius Health Group 7.4, Navio MD 8.5. How we are paid

What the record shows

  1. 01

    Neither Aurelius Health Group nor Navio MD has an FDA warning letter on record.

  2. 02

    Navio MD names The Pharmacy Hub, a 503A pharmacy. Aurelius Health Group names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, Navio MD costs $120 less a year at standing rates: $189 a month against $199 a month at Aurelius Health Group.

  4. 04

    Only Navio MD lists a price for brand-name tirzepatide pen.

  5. 05

    Navio MD lists all 50 states. Aurelius Health Group publishes no state list.

  6. 06

    Aurelius Health Group states you can cancel at any time; Navio MD does not state its cancellation terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Aurelius Health Group

Navio MD

Compounded tirzepatide injection

$199/mo

$2,388 a year

$189/moLower

$2,268 a year

Brand-name tirzepatide pen
Not sold or not priced

$445/mo

$5,340 a year

Price includes
Medication, clinician visits
Not stated
Cancel any time
Yes, stated
Not stated
Minimum term
None
Not stated
Refunds
Full refund within 72 hours if no services received, or if medically disqualified; none for the current or past months
Not stated
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Aurelius Health Group: October 17, 2026. Navio MD: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Aurelius Health Group

7.4/10
  • States you can cancel at any time
  • Names no compounding pharmacy
  • Publishes no state list
Visit site

The case for Navio MD

8.5/10
  • $120 a year less on compounded tirzepatide injection
  • Sells brand-name tirzepatide pen, which Aurelius Health Group does not price
  • Names its compounding pharmacy
Visit Navio MD

Scores

Aurelius Health Group 7.4 · Navio MD 8.5 out of 10. Six weighted parts.

Value25%

6.6A
vs
B
7.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
10.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

5.5A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

Aurelius Health Group vs Navio MD: questions

Neither Aurelius Health Group nor Navio MD has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Navio MD names The Pharmacy Hub, a 503A pharmacy. Aurelius Health Group names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Navio MD, by $120 a year at standing rates. Aurelius Health Group: $199 a month, about $2,388 a year. Navio MD: $189 a month, about $2,268 a year.
Aurelius Health Group states you can cancel at any time; refunds: full refund within 72 hours if no services received, or if medically disqualified; none for the current or past months. Navio MD does not state its cancellation terms.
Neither Aurelius Health Group nor Navio MD pays us. Links to them earn nothing. Scores: Aurelius Health Group 7.4, Navio MD 8.5.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks